Fig. 2From: Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case–control studyComparison of the steady-state plasma concentrations of pyrimethamine (a) and sulfadiazine (b) in pregnant women (PT; N = 89) and in women with ocular toxoplasmosis (OT; N = 17). Red lines: lower and upper target concentrations of pyrimethamine (700 and 1300 µg/l)14 and sulfadiazine (50 and 150 mg/l)21Back to article page